BG Medicine to Highlight Role of Galectin-3 Testing in Reducing Unplanned Hospital Readmissions at the 2012 American Heart Association (AHA) Scientific Sessions

BG Medicine to Highlight Role of Galectin-3 Testing in Reducing Unplanned Hospital Readmissions at the 2012 American Heart Association (AHA) Scientific Sessions

November 5, 2012

WALTHAM, Mass.

Ensemble Therapeutics and Boehringer Ingelheim Initiate Collaboration to Discover Macrocycle Drug Candidates

Ensemble Therapeutics and Boehringer Ingelheim Initiate Collaboration to Discover Macrocycle Drug Candidates

November 1, 2012

Collaboration to deploy Ensemble's innovative platform to discover small molecule drug candidates for Boehringer Ingelheim's targets

CAMBRIDGE, Mass., Nov 01, 2012 (BUSINESS WIRE) -- Ensemble Therapeutics today announced the initiation of a research collaboration with Boehringer Ingelheim to discover drug candidates of a novel class of small molecule drugs, called macrocycles, against several high-value pharmaceutical targets specified by Boehringer Ingelheim.

Avedro and EyeGate Pharma Enter Agreement for Corneal Cross-linking IP

Avedro and EyeGate Pharma Enter Agreement for Corneal Cross-linking IP

October 25, 2012

Avedro to hold exclusive license to broad iontophoresis patent portfolio

WikiCell Designs’ Edible Food and Beverage Packaging Receives Prestigious SIAL Global Food Industry Award

WikiCell Designs’ Edible Food and Beverage Packaging Receives Prestigious SIAL Global Food Industry Award

October 22, 2012

LS9 Selected as a Top 10 Venture-Backed Green Company by The Wall Street Journal

LS9 Selected as a Top 10 Venture-Backed Green Company by The Wall Street Journal

October 19, 2012

(GLOBE NEWSWIRE) -- LS9, Inc., a technology leader in the development of renewable and sustainable chemicals and fuels, today announced that the The Wall Street Journal selected the Company as one of the 2012 Top 10 Venture-Backed Green Companies.

BG Medicine, Inc. Appoints Charles H. Abdalian, Jr. as Chief Financial Officer

BG Medicine, Inc. Appoints Charles H. Abdalian, Jr. as Chief Financial Officer

October 18, 2012

WALTHAM, Mass., Oct. 18, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that it has appointed Charles H. Abdalian, Jr., as the company's Executive Vice President, Chief Financial Officer. Mr.

Joule, LS9 and Novomer Named to the Global Cleantech 100 2012

Joule, LS9 and Novomer Named to the Global Cleantech 100 2012

October 17, 2012

Welcome to the Global Cleantech 100 2012

The Global Cleantech 100 represents innovation and highlights the companies most likely to make a significant market impact in the next 5-10 years

The OCS™ Lung Initial European Clinical Experience Featured in The Lancet

The OCS™ Lung Initial European Clinical Experience Featured in The Lancet

October 10, 2012

Andover, Mass., October 10, 2012, The Lancet has published the initial series of successful lung transplants demonstrating the feasibility and safety of using the Organ Care System™ (OCS™) Lung technology, at Hannover Medical Schoo

Keraflex® Keratoconus Treatment Study Begins in US

Keraflex® Keratoconus Treatment Study Begins in US

October 11, 2012

Hersh Vision Group is the first to offer this novel keratoconus treatment

Life Sciences Venture Funding Drops

Life Sciences Venture Funding Drops

October 5, 2012

In today’s economy, capital is much more difficult to raise, and the various sources of investment, from private angels to larger VC firms, are understandably much more cautious and conservative about where they place their money. “The economic recession made its impact on life sciences investments, as there have been negative returns on investments for the last 12 years.